ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 288 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2021. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $327,787 | -24.6% | 12,199 | 0.0% | 0.06% | -22.2% |
Q2 2023 | $435,016 | +12.7% | 12,199 | -19.7% | 0.07% | +5.9% |
Q1 2023 | $386,055 | -37.4% | 15,199 | 0.0% | 0.07% | -41.9% |
Q4 2022 | $616,471 | +20.6% | 15,199 | -1.6% | 0.12% | +9.3% |
Q3 2022 | $511,000 | -6.1% | 15,448 | 0.0% | 0.11% | +0.9% |
Q2 2022 | $544,000 | -23.5% | 15,448 | -0.0% | 0.11% | -12.4% |
Q1 2022 | $711,000 | -30.6% | 15,453 | 0.0% | 0.12% | -32.8% |
Q4 2021 | $1,025,000 | +6.2% | 15,453 | 0.0% | 0.18% | -3.7% |
Q3 2021 | $965,000 | -24.6% | 15,453 | 0.0% | 0.19% | -25.5% |
Q2 2021 | $1,280,000 | +27.9% | 15,453 | +2.4% | 0.25% | +15.7% |
Q1 2021 | $1,001,000 | -13.6% | 15,089 | 0.0% | 0.22% | -19.3% |
Q4 2020 | $1,158,000 | +78.2% | 15,089 | 0.0% | 0.27% | +52.8% |
Q3 2020 | $650,000 | -0.3% | 15,089 | 0.0% | 0.18% | -3.8% |
Q2 2020 | $652,000 | +50.2% | 15,089 | 0.0% | 0.18% | +21.2% |
Q1 2020 | $434,000 | -54.6% | 15,089 | 0.0% | 0.15% | -43.4% |
Q4 2019 | $957,000 | +126.2% | 15,089 | +0.6% | 0.27% | +107.0% |
Q3 2019 | $423,000 | +59.6% | 15,000 | +50.0% | 0.13% | +61.2% |
Q2 2019 | $265,000 | +44.0% | 10,000 | 0.0% | 0.08% | +40.4% |
Q1 2019 | $184,000 | +48.4% | 10,000 | 0.0% | 0.06% | +26.7% |
Q4 2018 | $124,000 | – | 10,000 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |